Related by context. Frequent words. (Click for all words.) 65 Panzem R 64 Phase 1b trial 63 TOCOSOL Paclitaxel 62 forodesine 61 confirmatory Phase 3 60 confirmatory Phase III 60 elotuzumab 60 deforolimus 59 Phase 2b clinical 59 LibiGel 59 Entereg R 59 Fibrillex TM 59 Omigard 59 efficacy tolerability 58 NASDAQ BPAX 58 Phase IIb trials 58 R sorafenib tablets 58 SILENOR TM 58 pafuramidine 58 liprotamase 58 INCB# [001] 58 Shigamabs ® 58 TRISENOX 58 Phase Ib 58 Phase 2a trial 58 Zerenex 58 NEUMUNE 57 phase IIb 57 talactoferrin 57 Plenaxis R 57 celgosivir 57 phase IIb clinical 57 Anturol 57 dalbavancin 57 ganetespib 57 ATryn ® 56 Asentar 56 FermaVir 56 Phase IIa clinical trials 56 oral calcitonin 56 NEBIDO 56 Allovectin 7 R 56 Icatibant 56 registrational 56 MOZOBIL 56 AGGRASTAT ® 56 TOLAMBA 56 FavId 56 PXD# 56 Bicifadine 56 phase IIa clinical 56 isavuconazole 56 ISTODAX 56 Board DSMB 56 PS# [001] 56 Genitope Corporation 56 Phenoptin 56 PEG SN# 56 alvimopan 56 IIa trial 56 ONTAK 56 bremelanotide 56 include LibiGel ® 56 relapsed refractory multiple myeloma 56 registrational trial 56 ocrelizumab 55 vernakalant oral 55 QuatRx 55 BioSante 55 tanespimycin 55 Diamyd R 55 enzastaurin 55 Protexia R 55 Exploit collaboration 55 Urocidin 55 atacicept 55 BioSante Pharmaceuticals 55 IND submission 55 TORISEL 55 axitinib 55 SAR# [004] 55 PREOS 55 Trizytek 55 AeroLEF R 55 Nymox Pharmaceutical Corporation 55 ponatinib 54 dirucotide 54 Rotarix R 54 bicifadine 54 phase IIa 54 ridaforolimus 54 IND enabling 54 SinuNase 54 romidepsin 54 bazedoxifene 54 tesmilifene 54 BrachySil 54 NUEDEXTA 54 TELCYTA 54 Topical Interferon Alpha 2b 54 NDA submission